These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 35844804)

  • 21. Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer.
    Bi X; Wang J; Liu C
    Biomolecules; 2024 Jul; 14(8):. PubMed ID: 39199305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of circular RNAs and gut microbiome in gastrointestinal cancers and therapeutic targets.
    Abdullah ST; Abdullah SR; Hussen BM; Younis YM; Rasul MF; Taheri M
    Noncoding RNA Res; 2024 Mar; 9(1):236-252. PubMed ID: 38192436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smart capsule for targeted proximal colon microbiome sampling.
    Nejati S; Wang J; Sedaghat S; Balog NK; Long AM; Rivera UH; Kasi V; Park K; Johnson JS; Verma MS; Rahimi R
    Acta Biomater; 2022 Dec; 154():83-96. PubMed ID: 36162763
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the cross-talk between human microbiota and gastrointestinal cancer for developing potential diagnostic and prognostic biomarkers.
    Kashyap S; Pal S; Chandan G; Saini V; Chakrabarti S; Saini NK; Mittal A; Thakur VK; Saini AK; Saini RV
    Semin Cancer Biol; 2022 Nov; 86(Pt 3):643-651. PubMed ID: 33971261
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential.
    Saus E; Iraola-Guzmán S; Willis JR; Brunet-Vega A; Gabaldón T
    Mol Aspects Med; 2019 Oct; 69():93-106. PubMed ID: 31082399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of gut microbiota in cancer treatment: friend or foe?
    Cheng WY; Wu CY; Yu J
    Gut; 2020 Oct; 69(10):1867-1876. PubMed ID: 32759302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Gut Microbial Metabolites in the Pathogenesis of Primary Liver Cancers.
    Pallozzi M; De Gaetano V; Di Tommaso N; Cerrito L; Santopaolo F; Stella L; Gasbarrini A; Ponziani FR
    Nutrients; 2024 Jul; 16(14):. PubMed ID: 39064815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can we change our microbiome to prevent colorectal cancer development?
    Manzat-Saplacan RM; Mircea PA; Balacescu L; Chira RI; Berindan-Neagoe I; Balacescu O
    Acta Oncol; 2015; 54(8):1085-95. PubMed ID: 26073561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interactions between the gut microbiota-derived functional factors and intestinal epithelial cells - implication in the microbiota-host mutualism.
    Kaur H; Ali SA; Yan F
    Front Immunol; 2022; 13():1006081. PubMed ID: 36159834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review).
    Kumavath R; Pavithran H; Paul S; Anju VT; Busi S; Dyavaiah M
    Int J Oncol; 2024 Jan; 64(1):. PubMed ID: 37997816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Narrative Review: Immunometabolic Interactions of Host-Gut Microbiota and Botanical Active Ingredients in Gastrointestinal Cancers.
    Li S; Feng W; Wu J; Cui H; Wang Y; Liang T; An J; Chen W; Guo Z; Lei H
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201782
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Potential of the Gut Microbiome to Reshape the Cancer Therapy Paradigm: A Review.
    Liu L; Shah K
    JAMA Oncol; 2022 Jul; 8(7):1059-1067. PubMed ID: 35482355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut microbiota in colorectal cancer development and therapy.
    Wong CC; Yu J
    Nat Rev Clin Oncol; 2023 Jul; 20(7):429-452. PubMed ID: 37169888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Microbial regulation of tumor development and responses to tumor therapy].
    Zeissig S
    Z Gastroenterol; 2019 Jul; 57(7):883-888. PubMed ID: 31288284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intracellular glycogen accumulation by human gut commensals as a niche adaptation trait.
    Esteban-Torres M; Ruiz L; Rossini V; Nally K; van Sinderen D
    Gut Microbes; 2023; 15(1):2235067. PubMed ID: 37526383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatocellular Carcinoma Immunotherapy and the Potential Influence of Gut Microbiome.
    Temraz S; Nassar F; Kreidieh F; Mukherji D; Shamseddine A; Nasr R
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potential effects of gut microbiota on host cancers: focus on immunity, DNA damage, cellular pathways, and anticancer therapy.
    Sun J; Chen F; Wu G
    ISME J; 2023 Oct; 17(10):1535-1551. PubMed ID: 37553473
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered gut microbiota in hepatocellular carcinoma: Insights into the pathogenic mechanism and preclinical to clinical findings.
    Das BK
    APMIS; 2022 Dec; 130(12):719-740. PubMed ID: 36321381
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remodeling of the Gut Microbiota in Colorectal Cancer and its Association with Obesity.
    Zafari N; Velayati M; Mehrabadi S; Damavandi S; Khazaei M; Hassanian SM; Ferns GA; Avan A
    Curr Pharm Des; 2023; 29(4):256-271. PubMed ID: 36654469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis.
    Jia W; Xie G; Jia W
    Nat Rev Gastroenterol Hepatol; 2018 Feb; 15(2):111-128. PubMed ID: 29018272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.